Atypical teratoid rhabdoid tumor with extraneural metastases: a case report with genomic analysis
Authors:
- Nausheen YaqoobNYNausheen Yaqoob
- Boris ItkinBIBoris Itkin
- Syeda Sara TajammulSTSyeda Sara Tajammul
- Muna Mubarak Al JabriMJMuna Mubarak Al Jabri
- Zahida NiazZNZahida Niaz
- Ravikanth BalajiRBRavikanth Balaji
- Ahmed Al AzriAAAhmed Al Azri
- Ibrahim Hassan AlhaddabiIAIbrahim Hassan Alhaddabi
- Shoaib Al-ZadjaliSAShoaib Al-Zadjali
- Prashant DeshpandePDPrashant Deshpande
- 11 December 2025
- journal article
- case report
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 413
Abstract
Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive malignancy localized to the neuroaxis. It predominantly affects infants and young children, with exceedingly rare occurrences in adolescents and young adults. While its central nervous system (CNS) dissemination is common, extraneural metastases are exceptionally rare. We present a case of brain ATRT in a 16-year-old patient who, 8 months after the initial remission, developed an extraneural relapse involving visceral and skeletal sites. This unusual presentation posed significant diagnostic challenges in differentiating relapse from a second primary rhabdoid neoplasm. Comparative genomic analysis using a multigene panel found identical mutations in both the primary CNS tumor and a relapsed lesion, confirming their common clonal origin and ruling out a second de novo malignancy. Our case underscores the importance of awareness about the possibility of systemic relapse of ATRT. To our knowledge, this is the first report of applying comparative genomic profiling to discriminate between metastatic relapse and a second primary. Larger studies are needed to validate this approach in diverse tumor types.Keywords
This publication has 17 references indexed in Scilit:
- Approaches for prevention of tumors in patients with rhabdoid tumor predisposition syndromeNeuro-Oncology Advances, 2024
- SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni SyndromeAmerican Journal of Surgical Pathology, 2022
- Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell InfiltrationCell Reports, 2019
- p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid TumorsCancer Cell, 2019
- A systematic review of shunt-related extraneural metastases of primary central nervous system tumorsClinical Neurology and Neurosurgery, 2018
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesCancer Cell, 2016
- Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumorsPediatric Blood & Cancer, 2012
- Extraneural metastasis in intracranial tumors in children: the experience of a single centerJournal of Neuro-Oncology, 2006
- Metastasis to and from the central nervous system–the ‘relatively protected site’The Lancet Oncology, 2002
- SWI/SNF Complex Interacts with Tumor Suppressor p53 and Is Necessary for the Activation of p53-mediated TranscriptionJournal of Biological Chemistry, 2002